Fortunately, this study indicates that the UBA1-E2 interaction is a feasible target for the development of specific small-molecule UBA1 activity enhancers, which will be facilitated by further research into the mechanism governing AF-enhanced UBA1 and E2 interaction. Here, UBA1 is linked to atrial fibrillation.